During the past decade, Gloucestershire Oncology Centre at Cheltenham General Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gloucestershire Oncology Centre at Cheltenham General Hospital" #1 sponsor was "Medical Research Council" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "University College, London" with 3 trials sponsored, "Wales Cancer Trials Unit" with 2 trials sponsored and "Cancer Research UK" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gloucestershire Oncology Centre at Cheltenham General Hospital" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Velindre NHS Trust" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Gloucestershire Oncology Centre at Cheltenham General Hospital" are "Breast Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Lymphoma" (3 trials), "Metastatic Cancer" (3 trials) and "Ovarian Cancer" (3 trials). Many other conditions were trialed in "Gloucestershire Oncology Centre at Cheltenham General Hospital" in a lesser frequency.

Most popular intervention types in "Gloucestershire Oncology Centre at Cheltenham General Hospital" are "Drug" (22 trials), "Procedure" (11 trials), "Biological" (8 trials), "Other" (6 trials) and "Genetic" (3 trials). Other intervention types were less common.

The name of intervention was led by "quality-of-life assessment" (6 trials), "cisplatin" (5 trials), "carboplatin" (4 trials), "Cyclophosphamide" (3 trials) and "adjuvant therapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Gloucestershire Oncology Centre at Cheltenham General Hospital" are 18 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Gloucestershire Oncology Centre at Cheltenham General Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Gloucestershire Oncology Centre at Cheltenham General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gloucestershire Oncology Centre at Cheltenham General Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".